Cannabis Investing Supreme Pharmaceuticals Inc. Changes Name to The Supreme Cannabis Company, Inc. and Announces Conversion of Approximately $17.4 Million Aggregate Principal Amount of 10% Unsecured Convertible Debentures Due 2019
Cannabis Investing Supreme Closes Second Tranche of Private Placement for Aggregate Proceeds of $4.34m and Secures Additional Long Term Supply Agreement
Juggernaut Announces Strategic Investment by Crescat Capital Funds for 28.95% Ownership - Dr. Quinton Hennigh Technical Advisor
